CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


07-June-2011
Cerilliant Introduces New DEA exempt, Certified Spiking Solution® of Demoxepam & Certified Solution Standard of Demoxepam-D5

Demoxepam, 1.0 mg/mL D-079
1.0 mg/mL in Acetonitrile

A benzodiazepine drug and anticonvulsant, demoxepam is also a primary metabolite of chlordiazepoxide, marketed as Klopoxid or Librax for the treatment of anxiety and muscle spasms or pain.

Demoxepam-D5, 100 µg/mL D-080
100 ug/mL in Acetonitrile

An internal standard suitable for GC/MS or LC/MS applications with chlordiazepoxide or demoxepam such as toxicology analysis, forensic testing, pain prescription monitoring, or isotope dilution methods. Demoxepam is a benzodiazepine drug and anticonvulsant as well as a primary metabolite of chlordiazepoxide, marketed as Klopoxid or Librax for the treatment of anxiety and muscle spasms or pain.

We provide a wide selection of DEA exempt, certified solution standards of numerous benzodiazepines and their metabolites and internal standards, including demoxepam (D-079), chlordiazepoxide (C-022) and chlordiazepoxide-D5 (C-912).


Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn